Research and Clinical Trials

Find A Clinical Trial

We are dedicated to offering you the latest and most innovative cancer care. Our doctors and research team will match you to the trial that is right for you. They will also discuss the risks and benefits of participating in a particular trial. We collaborate with Dayton Clinical Oncology Program as well as offering the following trials to bring research right here… close to home.

We are currently enrolling for the following trials:

LUNG       Stage IV
BeiGene AdvanTIG – 205: Phase II Study of Ociperlimab (BGB-A1217) and Tislelizumab With Chemotherapy NCT 05014815 

PROSTATE  - Localized High Risk
MSKCC c20-252: Phase III Darolutamide augments standard therapy for localized very High-Risk Cancer of the Prostate NCT 04136353

Stage IV
DORA c16-174: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castrate Resistant Prostate Cancer (mCRPC) NCT 03574571

POINT PBP-301: Phase III Trial of 177Lu-PNT2002 for Metastatic Castrate Resistant Prostate Cancer NCT04647526

For more information regarding these trials, call our Clinical Research Center at 937-771-2287 or email or go to and enter the NCT number.